13 employees
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
2016
$30M
from 2 investors over 2 rounds
Disarm Therapeutics raised $30M on September 19, 2017
Investors: Atlas Venture and Lightstone Ventures